Skip to main content
SpringerLink
Log in

Heart Failure: Natriuretic Peptide Use in the Hospital

  • Chapter
  • First Online:
Cardiac Biomarkers

  • 1171 Accesses

Abstract

Acute decompensated heart failure (ADHF) is a leading cause of hospitalization amongst elderly in the U.S. The role of natriuretic peptides (NPs) is clear in the evaluation of acute dyspnea to help diagnose ADHF. NPs are quantitative markers of wall stress and reflect severity of heart failure. In the inpatient management of ADHF, serial sampling and recognition of down-trending NPs is a powerful indicator of patients who are at lower risk for future adverse events. Serial monitoring at least once during hospitalization (or if clinical uncertainty exists) and a pre-discharge NP should be checked to ensure patients are appropriate for discharge. If persistent elevation occurs, alternate etiologies for this should be considered and medications should be further up-titrated and optimized prior to discharge.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Maisel AS. Use of BNP levels in monitoring hospitalized heart failure patients with heart failure. Heart Fail Rev. 2003;8:339–44.

    Article  CAS  PubMed  Google Scholar 

  2. Troughton RW, Richards AM. Outpatient monitoring and treatment of chronic heart failure guided by amino-terminal Pro-B-type natriuretic peptide measurement. Am J Cardiol. 2008;101(Suppl):72A–5.

    Article  CAS  Google Scholar 

  3. Tsutamoto T, Wada A, Maeda K, et al. Effect of spirinolactone on plasma brain natriuretic peptide and left ventricular remodeling in patients with congestive heart failure. J Am Coll Cardiol. 2001;37:1228–33.

    Article  CAS  PubMed  Google Scholar 

  4. Rousseau MF, Gurne O, Duprez D, et al. Beneficial neurohormonal profile of spirinolactone in severe congestive heart failure: results from the rales neurohormonal substudy. J Am Coll Cardiol. 2002;40:1596–601.

    Article  CAS  PubMed  Google Scholar 

  5. Kohno M, Minami M, Kano H, et al. Effect of angiotensin-converting enzyme inhibitor on left ventricular parameters and circulating brain natriuretic peptide in elderly hypertensives with left ventricular hypertrophy. Metabolism. 2000;49:1356–60.

    Article  CAS  PubMed  Google Scholar 

  6. Kazanegra R, Cheng V, Garcia A, et al. A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: a pilot study. J Card Fail. 2001;7:21–9.

    Article  CAS  PubMed  Google Scholar 

  7. Munagala VK, Burnett Jr JC, Redfield MM. The natriuretic peptides in cardiovascular medicine. Curr Probl Cardiol. 2004;29:707–69.

    Article  PubMed  Google Scholar 

  8. Johnson W, Omland T, Hall C, Lucas C, Myking OL, Collins C, Pfeffer M, Rouleau JL, Stevenson LW. Neurohormonal activation rapidly decreases after intravenous therapy with diuretics and vasodilators for class IV heart failure. J Am Coll Cardiol. 2002;39(10):1623–9.

    Article  CAS  PubMed  Google Scholar 

  9. Fonarow GC, Peacock WF, Phillips CO, Givertz MM, Lopatin M. Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure. J Am Coll Cardiol. 2007;49:1943–50.

    Article  CAS  PubMed  Google Scholar 

  10. Yu CM, Sanderson JE. Plasma brain natriuretic peptide—an independent predictor of cardiovascular mortality in acute heart failure. Eur J Heart Fail. 1999;1:59–65.

    Article  CAS  PubMed  Google Scholar 

  11. Tamura K, Takahashi N, Nakatani Y, Onishi S, Iwasaka T. Prognostic impact of plasma brain natriuretic peptide for cardiac events in elderly patients with congestive heart failure. Gerontology. 2001;47:46–51.

    Article  CAS  PubMed  Google Scholar 

  12. Harrison A, Morrison LK, Krishnaswamy P, Kazanegra R, Clopton P, Dao Q, et al. B-type natriuretic peptide predicts future cardiac events in patients presenting to the emergency department with dyspnea. Ann Emerg Med. 2002;39:131–8.

    Article  PubMed  Google Scholar 

  13. O’Brien RJ, Squire IB, Demme B, Davies JE, Ng LL. Pre-discharge, but not admission, levels of NT-proBNP predict adverse prognosis following acute LVF. Eur J Heart Fail. 2003;5(4):499–506.

    Article  PubMed  Google Scholar 

  14. Logeart D, Thabut G, Jourdain P, Chavelas C, Beyne P, Beauvais F, Bouvier E, Solal AC. Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure. J Am Coll Cardiol. 2004;43(4):635–41.

    Article  CAS  PubMed  Google Scholar 

  15. Bettencourt P, Azevedo A, Pimenta J, Frioes F, Ferreira S, Ferreira A. N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients. Circulation. 2004;110:2168–74.

    Article  CAS  PubMed  Google Scholar 

  16. Kociol RD, Horton JR, Fonarow GC, Reyes EM, Shaw LK, O’Connor CM, Felker GM, Hernandez AF. Admission, discharge, or change in B-type natriuretic peptide and long-term outcomes: data from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF) linked to Medicare claims. Circ Heart Fail. 2011;4(5):628–36.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, University of California San Diego, San Diego, CA, USA

    Kevin Shah MD

  2. Department of Internal Medicine, UCSD Medical Center, San Diego, CA, USA

    James Iwaz MD

Authors
  1. Kevin Shah MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. James Iwaz MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kevin Shah MD .

Editor information

Editors and Affiliations

  1. Division of Cardiovascular Medicine, University of California San Diego Division of Cardiovascular Medicine, La Jolla, California, USA

    Alan S. Maisel

  2. Cardiology Department, Mayo Clinic Cardiology Department, ROCHESTER, Minnesota, USA

    Allan S. Jaffe

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Shah, K., Iwaz, J. (2016). Heart Failure: Natriuretic Peptide Use in the Hospital. In: Maisel, A., Jaffe, A. (eds) Cardiac Biomarkers. Springer, Cham. https://doi.org/10.1007/978-3-319-42982-3_17

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-42982-3_17

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-42980-9

  • Online ISBN: 978-3-319-42982-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation